Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046101

Options or other derivatives

  • Chief Scientific Officer acquired 408,812 shares (grant or award)
  • Chief Scientific Officer returned 408,812 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Aftab Blake Chief Scientific Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −50,000 0 D: show line 1 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D: show line 2 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −56,612 0 D: show line 3 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +56,612 56,612 D: show line 4 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −125,000 0 D: show line 5 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D: show line 6 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −60,000 0 D: show line 7 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +60,000 60,000 D: show line 8 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −117,200 0 D: show line 9 in the form
Aftab Blake Chief Scientific Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +117,200 117,200 D: show line 10 in the form
Loading xslF345X05/doc4.xml…